Olanow, C Warren <br/><br/>
Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study.  [electronic resource] 

 -  The Lancet. Neurology  02 2020 
 - 135-144 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-4465 
<br/><br/><label>Standard No.: </label>10.1016/S1474-4422(19)30396-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Sublingual<br/>Adult<br/>Aged<br/>Antiparkinson Agents--therapeutic use<br/>Apomorphine--administration & dosage<br/>Canada<br/>Double-Blind Method<br/>Dyskinesias--drug therapy<br/>Female<br/>Humans<br/>Levodopa--therapeutic use<br/>Male<br/>Middle Aged<br/>Parkinson Disease--drug therapy<br/>Treatment Outcome<br/>United States